Oncologists' attitudes toward KRAS testing: a multisite study

Recent discoveries promise increasingly to help oncologists individually tailor anticancer therapy to their patients’ molecular tumor characteristics. One such promising molecular diagnostic is Kirsten ras (KRAS) tumor mutation testing for metastatic colorectal cancer (mCRC) patients. In the current...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harris, Julie N, Liljestrand, Petra, Alexander, Gwen L, Goddard, Katrina A B, Kauffman, Tia, Kolevska, Tatjana, McCarty, Catherine, O'Neill, Suzanne, Pawloski, Pamala, Rahm, Alanna, Williams, Andrew, Somkin, Carol P
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2013
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892392/
https://ncbi.nlm.nih.gov/pubmed/24403261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados